Lee Ainslie’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Lee Ainslie's BMY Position: Q3 2026 in Review
Lee Ainslie opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 34,008 shares worth $2.12M. The stake represents 0.02% of the portfolio and ranks #98 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in BMY as recently as Q1 2021.
Lee Ainslie first reported a position in BMY in Q3 2018 and has held it in 11 quarters since. The position peaked at $9.23M in Q3 2018. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Lee Ainslie held 34,008 shares of Bristol-Myers Squibb worth $2.12M as of Q3 2026.
- Bristol-Myers Squibb was a new Lee Ainslie position in Q3 2026.
- Bristol-Myers Squibb made up 0.02% of Lee Ainslie's portfolio in Q3 2026, its #98 holding.
- Lee Ainslie first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 11 quarters since.
- Lee Ainslie's Bristol-Myers Squibb position peaked at $9.23M in Q3 2018.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.